Cargando…

Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies

Detalles Bibliográficos
Autores principales: Wang, Yiting, Shi, Hubing, Meng, Huan, Xu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545036/
https://www.ncbi.nlm.nih.gov/pubmed/33101043
http://dx.doi.org/10.3389/fphar.2020.591188
_version_ 1783591948766937088
author Wang, Yiting
Shi, Hubing
Meng, Huan
Xu, Jie
author_facet Wang, Yiting
Shi, Hubing
Meng, Huan
Xu, Jie
author_sort Wang, Yiting
collection PubMed
description
format Online
Article
Text
id pubmed-7545036
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-75450362020-10-22 Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies Wang, Yiting Shi, Hubing Meng, Huan Xu, Jie Front Pharmacol Pharmacology Frontiers Media S.A. 2020-09-25 /pmc/articles/PMC7545036/ /pubmed/33101043 http://dx.doi.org/10.3389/fphar.2020.591188 Text en Copyright © 2020 Wang, Shi, Meng and Xu http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Yiting
Shi, Hubing
Meng, Huan
Xu, Jie
Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
title Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
title_full Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
title_fullStr Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
title_full_unstemmed Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
title_short Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
title_sort editorial: targeting the pd-1/pd-l1 cancer immune evasion axis: challenges and emerging strategies
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7545036/
https://www.ncbi.nlm.nih.gov/pubmed/33101043
http://dx.doi.org/10.3389/fphar.2020.591188
work_keys_str_mv AT wangyiting editorialtargetingthepd1pdl1cancerimmuneevasionaxischallengesandemergingstrategies
AT shihubing editorialtargetingthepd1pdl1cancerimmuneevasionaxischallengesandemergingstrategies
AT menghuan editorialtargetingthepd1pdl1cancerimmuneevasionaxischallengesandemergingstrategies
AT xujie editorialtargetingthepd1pdl1cancerimmuneevasionaxischallengesandemergingstrategies